"43857-0405-1" National Drug Code (NDC)

Pneumotox 30 mL in 1 BOTTLE, DROPPER (43857-0405-1)
(BioActive Nutritional, Inc.)

NDC Code43857-0405-1
Package Description30 mL in 1 BOTTLE, DROPPER (43857-0405-1)
Product NDC43857-0405
Product Type NameHUMAN OTC DRUG
Proprietary NamePneumotox
Non-Proprietary NameTriticum Aestivum, Alfalfa, Arnica Montana, Asclepias Tuberosa, Chamomilla, Echinacea (angustifolia), Eucalyptus Globulus, Fucus Vesiculosus, Hordeum Vulgare, Laminaria Digitata, Nasturtium Aquaticum, Plantago Major, Raphanus Sativus, Trifolium Pratense, Trigonella Foenum-graecum, Symphytum Officinale, Lung (suis), Oryza Sativa, Silicea, Acetone, Sodium Tripolyphosphate, Propylene Glycol, Sodium Benzene Sulfonate, Ammonium Muriaticum, Sodium Lauryl Sulfate, Terebinthina, Arsenicum Album
Dosage FormLIQUID
UsageORAL
Start Marketing Date20160803
End Marketing Date20230629
Marketing Category NameUNAPPROVED HOMEOPATHIC
ManufacturerBioActive Nutritional, Inc.
Substance NameACETONE; ALFALFA; AMMONIUM CHLORIDE; AMMONIUM THIOGLYCOLATE; ANHYDROUS CITRIC ACID; ANTHRAQUINONE; ARNICA MONTANA; ARSENIC TRIOXIDE; ASCLEPIAS TUBEROSA ROOT; DIMETHICONE; ECHINACEA ANGUSTIFOLIA; ETHYLENE GLYCOL; EUCALYPTUS GLOBULUS LEAF; FUCUS VESICULOSUS; GLUTARAL; GLYCOLIC ACID; HORDEUM VULGARE TOP; HYDROGEN PEROXIDE; LAMINARIA DIGITATA; MATRICARIA RECUTITA; METHYL METHACRYLATE; MONOETHANOLAMINE; NASTURTIUM OFFICINALE; NITRIC ACID; OENANTHE AQUATICA FRUIT; ORYZA SATIVA WHOLE; P-AMINOPHENOL; PALMITIC ACID; PARAFFIN; PHOSPHORIC ACID; PHOSPHORUS; PLANTAGO MAJOR; POLYACRYLIC ACID (8000 MW); PROPYL ALCOHOL; PROPYLENE GLYCOL; PULSATILLA VULGARIS; RAPHANUS SATIVUS; SILICON DIOXIDE; SODIUM BENZENESULFONATE; SODIUM CARBONATE; SODIUM CHLORIDE; SODIUM LAURYL SULFATE; SODIUM TRIPOLYPHOSPHATE; SUS SCROFA LUNG; SYMPHYTUM OFFICINALE WHOLE; TARTARIC ACID; TOLUENE-2,5-DIAMINE; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER; TRIGONELLA FOENUM-GRAECUM WHOLE; TRITICUM AESTIVUM WHOLE; TURPENTINE OIL
Strength9; 3; 9; 30; 30; 30; 3; 12; 3; 30; 3; 30; 3; 3; 30; 30; 3; 30; 3; 3; 30; 30; 3; 12; 12; 8; 30; 30; 30; 12; 12; 3; 30; 30; 9; 12; 3; 8; 9; 30; 12; 9; 9; 8; 6; 30; 30; 12; 3; 3; 1; 9
Strength Unit[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; 1/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacy ClassesAcidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Sclerosing Activity [MoA], Sclerosing Agent [EPC], Skin Barrier Activity [PE], Vascular Sclerosing Activity [PE]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/43857-0405-1